SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : Bayer CropScience Ltd

BSE: 506285 NSE: BAYERCROP ISIN: INE462A01022
  |   Sector:  Chemicals & Fertilizers   |   Industry:  Pesticides & Agrochemicals

Snapshot

Q.1 Which industry/sub-sector does Bayer CropScience Ltd belong to?
Bayer CropScience Ltd belongs to the Chemicals & Fertilizers sector, operating specifically within the Pesticides & Agrochemicals segment.
Q.2 Is Bayer CropScience Ltd a good quality company?
Bayer CropScience Ltd is a good quality company, based on a consistently good 10 year financial track record.
Q.3 Is Bayer CropScience Ltd undervalued or overvalued?
Bayer CropScience Ltd appears Undervalued, as its key valuation ratios are below with their past averages.
Q.4 Is Bayer CropScience Ltd a good buy now?
Bayer CropScience Ltd is a neutral opportunity now, based on stable price trend analysis suggesting prices may move sideways. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of Bayer CropScience Ltd?
Bayer CropScience Ltd revenue growth is 7.2% for FY-2025 , which is below its 5 year CAGR of 8.7% , indicating slower growth.
Q.2 Gross Profit margin of Bayer CropScience Ltd?
Bayer CropScience Ltd Gross profit margin which is the profit after deduction of direct costs, is 12.6% for FY-2025 , which is below its 5 year median of 16.4% , indicating decreasing margins.
Q.3 Operating Profit Margin of Bayer CropScience Ltd?
Bayer CropScience Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 12.61% for FY-2025 , which is below its 5 year median of 17.85% indicating decreasing margins.
Q.4 Net Profit Margin of Bayer CropScience Ltd?
Bayer CropScience Ltd Net Profit Margin is 10.38% for FY-2025 , is below with its 5 year median of 13.63%, indicating decreasing margins.
Current Level Historic Median
Gross Profit Margin 12.6 16.4
Operating Profit Margin 12.61 17.85
Net Profit Margin 10.38 13.63
Q.5 Return on Asset of Bayer CropScience Ltd?
Bayer CropScience Ltd Return on Asset is 7.09%, which is below its 5 year historical median of 9.51%, indicating deteriorated asset utilization efficiency.
Q.6 Return on Equity (ROE) of Bayer CropScience Ltd?
Bayer CropScience Ltd Return on equity is 19.93% for FY-2025 , which is below its historical median of 25.43%, indicating the business is making worse use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of Bayer CropScience Ltd?
Bayer CropScience Ltd Return on capital employed is 25.42% for FY-2025 , which is above its estimated weighted average cost of capital(WACC) 11.25%, indicating value creation.
Q.8 Cash conversion cycle of Bayer CropScience Ltd?
Bayer CropScience Ltd Cash conversion cycle is 103 days, above its historical median of 87 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.78 0.8
ROE 19.93 25.43
ROCE 25.42 33.88
Cash Conversion Cycle 103 days 87 days
Q.9 Debt to Equity ratio of Bayer CropScience Ltd?
Bayer CropScience Ltd Debt-to-Equity ratio is 0.00 , which is lower with the industry average of 0.27 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of Bayer CropScience Ltd?
Bayer CropScience Ltd Debt to cash flow from operations is 0 , which is at a healthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Bayer CropScience Ltd?
Promoters hold 71.43% of the Bayer CropScience Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Bayer CropScience Ltd vs industry peers?
Bayer CropScience Ltd revenue CAGR is 8.68% , compared to the industry median CAGR of 8.45% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 5,473.4 716.1
Gross Profit 689.6 68.5
Operating Profit 688 86
Net Profit 568 44
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.78 1.19
ROE 19.93 13.63
ROCE 25.42 16.98
Cash Conversion Cycle (days) 102.54 93

Valuation & price assessment

Q.1 Stock return of Bayer CropScience Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 2.5% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 2.5% -1.6% 5% -4.3%
Q.3 Valuation ratios of Bayer CropScience Ltd vs historical?
The current P/E is lower that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 32.12 36.12 24.15
Price to Book 6.69 7.68 2.51
Price to Sales 3.83 4.58 1.40
EV to EBITDA 22.51 25.00 12.63

Check more companies

1. Sumitomo Chemical
2. Bayer CropScience
3. Sharda Cropchem
4. Rallis India
5. Dhanuka Agritech
6. NACL Industries
7. Bhagiradha Chem
8. Bharat Rasayan
9. Insecticides India
10. GSP Crop Science
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×